… pathways, may represent a potential molecular target candidate in response to agents …
identify a molecular target. Based on these results we believe TR is a potential molecular target …

… The cyclin-dependent kinases remain a major focus as molecular targets with agents such
as flavopiridol which is in Phase II clinical trial and UCN-01 which is in Phase I clinical trial …

… trials for many different types of cancer. This review focuses on … molecular targets for cancer
therapy found in key pathway members and their corresponding experimental therapeutic …

… molecular link bridging inflammation and cancer. As a result, NFκB becomes an ideal molecular
target in controlling cancer … their cancer therapeutic and chemo-preventive effects [16]. …

… approaches for the development of therapeutic agents. This review … cancer and suggests
some directions toward future cancer therapy utilizing vimentin as a potential molecular target…

… Surprisingly, despite the broad theoretical impact of such molecules on integrin function,
and thus on pathology, the clear identification of discrete clinical niches for their use remains to …

… a molecular targeted therapy for cancer. In this paper, we focused on apoptosis induction to
identify molecular targets for colorectal cancer therapy… in human colorectal cancer tissues for …

… cancer therapy strategy. In addition, recent studies have shown that NF‐κB can also play a
tumor … in carcinogenesis and the therapeutic potential of targeting NF‐κB in cancer therapy. …

… –target interactions, particularly for older molecules, we highlight opportunities for repurposing
compounds as cancer therapeutics, … relevant affinities for new targets. Ideal candidates for …

… It, therefore, places Notch signaling as a potential target for cancer therapeutics. An … information
for the identification of molecular targets to design effective therapeutic strategies (Fig. 3). …